Coinfection with Giardia lamblia and Clostridium difficile after Use of Ranitidine

American Journal of the Medical Sciences

Volumn 327, Issue 2, 2004, Pages 91-93

  Khatami, Sayed Saeid ^a,b   Mukunda, Beejadi ^a   Ravakhah, Keyvan ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Huron Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ACHLORHYDRIA; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; DISEASE PREDISPOSITION; EPIGASTRIC PAIN; FECES ANALYSIS; GIARDIA LAMBLIA; HUMAN; INTESTINE INFECTION; MALE; RISK FACTOR; VOMITING; WEIGHT REDUCTION;

EID: 1242294562     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200402000-00007     Document Type: Article

References (25)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
2. Eglow R, Pothoulakis C, Itzkowitz S, et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J Clin Invest 1992;90:822-9.
3. Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to toxin A and B of Clostridium difficile. J Infect Dis 1983;148:93-100.
4. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
5. Brodsky RE, Spencer HC Jr, Schultz MG. Giardiasis in American travelers to the Soviet Union. J Infect Dis 1974; 130:319-23.
6. Hill DR, Nash TE. Intestinal flagellate and ciliate infections. In: Guerrant RL, Walker DA, Weller PF, editors. Tropical infectious diseases: principles, pathogens and practice. Philadelphia: WB Saunders; 1999. p. 703-20.
7. Sanduleanu S, Jonkers D, de Bruine A, et al. Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth. Dig Liver Dis 2001;33:707-19.
8. Gianella RA, Broitman SA, Zamchek N. Gastric acid barrier to ingested microorganism in man: studies in vivo and in vitro. Gut 1972;13:251-6.
9. Nwokolo CU, Loft DE, Holder R, et al. Increased incidence of bacterial diarrhea in patients taking gastric acid antisecretory drugs. Eur J Gastroenterol Hepatol 1994;6:697-9.
10. Neal KR, Briji O, Slack RC, et al. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for salmonella infection. Br Med J 1994;308:176.
11. Neal KR, Scott HM, Slack RC, et al. Omeprazole as a risk factor for Campylobacter gastroenteritis: case-control study. BMJ 1996;312:414-5.
12. Laine E, Ahnen D, McClain C, et al. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000;14:651-68.
13. Awad RW, Ward KL, Hawker PC. Fulminant pseudomembranous colitis (PMC) following triple therapy for Helicobacter pylori. J R Coll Surg Edinb 1994;39:319.
14. Harsch IA, Hahn EG, Konturek PC. Pseudomembranous colitis after eradication of Helicobacter pylori infection with a triple therapy. Med Sci Monit 2001;7:751-4.
15. Archimandritis A, Souyioultzis S, Katsorida M, et al. Clostridium difficile colitis associated with a triple regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori. J Intern Med 1998;243:251-3.
16. Shah S, Lewis A, Leopold D, et al. Gastric acid suppression does not promote clostridial diarrhea in the elderly. Q J Med 2000;93:175-81.
17. Thompson RD, Lestina LS, Bensen SP, et al. Lansoprazole-associated microscopic colitis: a case series. Am J Gastroenterol 2002;97:2908-13.
18. Mukherjee S. Diarrhea associated with lansoprazole. J Gastroenterol Hepatol 2003;18:602-3.
19. Reynaeri H, Fernandes E, Bourgain C, et al. Proton-pump inhibition and gastric giardiasis: a causal or casual association? J Gastroenterol 1995;30:775-8.
20. Kader SA, Mansour AM, Mohran Z, et al. A study on the relation between proton pump inhibitor and gastric giardiasis. J Egypt Soc Parasitol 1998;28:149-57.
21. Mukherjee S. Asymptomatic giardiasis-an association with proton pump inhibitors? Am J Gastroenterol 2000;95:3666-7.
22. Desai HG, Zaveri MP, Anita FP. Spontaneous and persisting decrease in maximal acid output. Br Med J 1971;1:313-5.
23. Jacobs A, Lawrie JH, Entwistle CC, et al. Gastric acid secretion in chronic iron deficiency anemia. Lancet 1966;2:190-2.
24. Stone WD. Gastric secretory response to iron therapy. Gut 1968;9:99-105.
25. Bockus HL, Bank J, Willard JH. Achlorhydria with a review of 210 cases in patients with gastrointestinal complaints. Am J Med Sci 1932;184:185-201.